Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / FATE - Fate Therapeutics EPS beats by $0.13 beats on revenue


FATE - Fate Therapeutics EPS beats by $0.13 beats on revenue

Fate Therapeutics (NASDAQ:FATE): Q3 GAAP EPS of -$0.45 beats by $0.13. Revenue of $14.23M (+88.2% Y/Y) beats by $5.56M. Press Release Cash, cash equivalents and investments as of September 30, 2021 were $803.6 million.

For further details see:

Fate Therapeutics EPS beats by $0.13, beats on revenue
Stock Information

Company Name: Fate Therapeutics Inc.
Stock Symbol: FATE
Market: NASDAQ
Website: fatetherapeutics.com

Menu

FATE FATE Quote FATE Short FATE News FATE Articles FATE Message Board
Get FATE Alerts

News, Short Squeeze, Breakout and More Instantly...